The disclosure initiative requires companies to disclose payments, collaborations and other Transfers of Value (ToV) made to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs). The type of collaborations include registering and attending medical conferences; taking part in clinical trials and research; patient education and awareness initiatives as well as details of specific interactions such as research and medical grants.

Healthcare Professional Payments

The EFPIA (European Federation of Pharmaceutical Industries and Associations) requires companies to report the following payments made to Healthcare Professionals (HCPs) and to Healthcare Organisations (HCOs):

For Transfers of Value to an HCO:

  • Donations and Grants to HCOs that support healthcare, including donations and grants (either cash or benefits in kind) to institutions, organisations or associations that are comprised of HCPs and/or that provide healthcare (governed by Article 11 of the EFPIA HCP Code).

  • Contribution to costs related to Events through HCOs or third parties, including sponsorship to HCPs to attend Events, such as:
    • Registration fees;
    • Sponsorship agreements with HCOs or with third parties appointed by an HCO to manage an Event; and travel and accommodation (to the extent governed by Article 10 of the EFPIA HCP Code).
    • Fees for Service and Consultancy.
    • Transfers of Value resulting from or related to contracts between Companies and institutions, organisations or associations of HCPs under which such institutions, organisations or associations provide any type of services to a Company or any other type of funding not covered in the previous categories. Fees, on the one hand, and on the other hand Transfers of Value relating to expenses agreed in the written agreement covering the activity will be disclosed as two separate amounts.

For Transfers of Value to an HCP:

  • Contribution to costs related to Events, such as:

    • Registration fees; and travel and accommodation (to the extent governed by Article 10
 of the EFPIA HCP Code).
  • Fees for Service and Consultancy. Transfers of Value resulting from or related to contracts between Companies and HCPs under which such HCPs provide any type of services to a Company or any other type of funding not covered in the previous categories. Fees and on the other hand Transfers of Value relating to expenses agreed in the written agreement covering the activity will be disclosed as two separate amounts.
(Section 3.02 of the EFPIA Code).

Aggregate Disclosure:

For Transfers of Value where certain information, which can be otherwise reasonably allocated to one of the categories set forth in Section 3.01 of the EFPIA Code, cannot be disclosed on an individual basis for legal reasons, the Company shall disclose the amounts attributable to such Transfers of Value in each Reporting Period on an aggregate basis. Such aggregate disclosure shall identify, for each category, (i) the number of Recipients covered by such disclosure, on an absolute basis and as a percentage of all Recipients, and (ii) the aggregate amount attributable to Transfers of Value to such Recipients.



Research and Development Transfers of Value:

Research and Development Transfers of Value in each Reporting Period shall be disclosed on an aggregate basis.

The Methodology provides detailed explanation on how the figures disclosed on this website have been calculated.


Countries:

In line with local Transparency Reporting requirements across our European offices, Jazz Pharmaceuticals is disclosing its interactions with Healthcare Professionals and Healthcare Organizations. Please click on the corresponding language tab for the methodology disclosure as well as a list of data for 2015.

The information is correct at the time of publishing (30th June 2016). The information can be subject to change and can be updated accordingly.

Austria

Deutsch English

Germany

Deutsch English

Italy

Italiano English

Poland

Polish English

Portugal

Português English

Spain

Español English

Switzerland

Deutsch Français English